Gerald M. Borok

1.4k total citations
17 papers, 1.1k citations indexed

About

Gerald M. Borok is a scholar working on Economics and Econometrics, Surgery and Geriatrics and Gerontology. According to data from OpenAlex, Gerald M. Borok has authored 17 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Economics and Econometrics, 7 papers in Surgery and 6 papers in Geriatrics and Gerontology. Recurrent topics in Gerald M. Borok's work include Health Systems, Economic Evaluations, Quality of Life (9 papers), Lipoproteins and Cardiovascular Health (6 papers) and Pharmaceutical Economics and Policy (4 papers). Gerald M. Borok is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (9 papers), Lipoproteins and Cardiovascular Health (6 papers) and Pharmaceutical Economics and Policy (4 papers). Gerald M. Borok collaborates with scholars based in United States, United Kingdom and Brazil. Gerald M. Borok's co-authors include Richard F. Hamman, George Howard, Mohammed Saad, Lynne E. Wagenknecht, Elizabeth J Mayer, Steven M. Haffner, Joseph V. Selby, Peter J. Savage, Marian Rewers and Richard N. Bergman and has published in prestigious journals such as New England Journal of Medicine, Journal of the American College of Cardiology and Journal of the American Geriatrics Society.

In The Last Decade

Gerald M. Borok

17 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gerald M. Borok United States 11 415 233 212 200 197 17 1.1k
Nicola Motterlini Ireland 19 196 0.5× 248 1.1× 219 1.0× 255 1.3× 102 0.5× 31 1.3k
Amit D. Raval United States 21 363 0.9× 332 1.4× 169 0.8× 156 0.8× 191 1.0× 80 1.3k
John A. Merenich United States 19 130 0.3× 260 1.1× 264 1.2× 183 0.9× 82 0.4× 39 934
Marietta Rottenkolber Germany 21 171 0.4× 288 1.2× 224 1.1× 130 0.7× 100 0.5× 66 1.4k
E Bercoff France 19 638 1.5× 213 0.9× 553 2.6× 104 0.5× 137 0.7× 62 1.8k
Magdalena Rosell Spain 8 260 0.6× 285 1.2× 180 0.8× 201 1.0× 41 0.2× 10 953
Luca Degli Esposti Italy 20 190 0.5× 318 1.4× 299 1.4× 540 2.7× 151 0.8× 200 1.7k
Pietro Gallina Italy 16 247 0.6× 264 1.1× 126 0.6× 120 0.6× 39 0.2× 27 987
Edward F. Tierney United States 14 289 0.7× 567 2.4× 160 0.8× 134 0.7× 48 0.2× 23 1.4k
Ishak A. Mansi United States 19 180 0.4× 163 0.7× 514 2.4× 197 1.0× 150 0.8× 77 1.2k

Countries citing papers authored by Gerald M. Borok

Since Specialization
Citations

This map shows the geographic impact of Gerald M. Borok's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerald M. Borok with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerald M. Borok more than expected).

Fields of papers citing papers by Gerald M. Borok

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gerald M. Borok. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerald M. Borok. The network helps show where Gerald M. Borok may publish in the future.

Co-authorship network of co-authors of Gerald M. Borok

This figure shows the co-authorship network connecting the top 25 collaborators of Gerald M. Borok. A scholar is included among the top collaborators of Gerald M. Borok based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gerald M. Borok. Gerald M. Borok is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Stein, Renato T., Louis Bont, Heather J. Zar, et al.. (2016). Respiratory syncytial virus hospitalization and mortality: Systematic review and meta‐analysis. Pediatric Pulmonology. 52(4). 556–569. 235 indexed citations
2.
An, Jaejin, Fang Niu, Nazia Rashid, et al.. (2014). TIME IN THERAPEUTIC RANGE ≥55% VERSUS <55% ON WARFARIN THERAPY OUTCOMES IN NON-VALVULAR ATRIAL FIBRILLATION PATIENTS. Journal of the American College of Cardiology. 63(12). A359–A359. 1 indexed citations
3.
Bullano, Michael, Siddhesh Kamat, Debra Wertz, et al.. (2007). Effectiveness of rosuvastatin versus atorvastatin in reducing lipid levels and achieving low-density-lipoprotein cholesterol goals in a usual care setting. American Journal of Health-System Pharmacy. 64(3). 276–284. 17 indexed citations
4.
Nichol, Michael B., Tara K. Knight, Gail Wygant, et al.. (2007). Quality of Anticoagulation Monitoring in Nonvalvular Atrial Fibrillation Patients: Comparison of Anticoagulation Clinic versus Usual Care. Annals of Pharmacotherapy. 42(1). 62–70. 45 indexed citations
5.
Song, Xue, et al.. (2006). A Projection of the Impact of Lipid-Lowering Therapy on High-Risk Employee Disability and Medical Costs. Journal of Occupational and Environmental Medicine. 48(10). 1014–1022. 8 indexed citations
6.
Bullano, Michael, Debra Wertz, Siddhesh Kamat, et al.. (2006). Effect of Rosuvastatin Compared with Other Statins on Lipid Levels and National Cholesterol Education Program Goal Attainment for Low‐Density Lipoprotein Cholesterol in a Usual Care Setting. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 26(4). 469–478. 51 indexed citations
7.
8.
Williams, Setareh A., et al.. (2006). An Evaluation of the Factors Associated with Statin Dose Management and Low-Density Lipoprotein-Cholesterol Goal Attainment. Disease Management & Health Outcomes. 14(1). 37–44. 1 indexed citations
9.
Wagenknecht, Lynne E., Elizabeth J Mayer, Marian Rewers, et al.. (1995). The Insulin Resistance Atherosclerosis Study (IRAS). Annals of Epidemiology. 5(6). 464–472. 436 indexed citations
10.
McCombs, Jeffrey S., Marisue Cody, Gerald M. Borok, et al.. (1995). Measuring the impact of patient counseling in the outpatient pharmacy setting: the research design of the Kaiser permanente/USC patient consultation study. Clinical Therapeutics. 17(6). 1188–1206. 16 indexed citations
11.
Oster, Gerry, Gerald M. Borok, Joseph Menzin, et al.. (1995). A randomized trial to assess effectiveness and cost in clinical practice: Rationale and design of the cholesterol reduction intervention study (CRIS). Controlled Clinical Trials. 16(1). 3–16. 27 indexed citations
12.
Reuben, David B., Gerald M. Borok, Girma Wolde-Tsadik, et al.. (1995). A Randomized Trial of Comprehensive Geriatric Assessment in the Care of Hospitalized Patients. New England Journal of Medicine. 332(20). 1345–1350. 191 indexed citations
13.
Borok, Gerald M., et al.. (1994). Rationale and Design of a Multi‐Center Randomized Trial of Comprehensive Geriatric Assessment Consultation for Hospitalized Patients in an HMO. Journal of the American Geriatrics Society. 42(5). 536–544. 25 indexed citations
14.
Reuben, David B., et al.. (1992). The Use of Targeting Criteria in Hospitalized HMO Patients: Results from the Demonstration Phase of the Hospitalized Older Persons Evaluation (HOPE) Study. Journal of the American Geriatrics Society. 40(5). 482–488. 28 indexed citations
15.
Borok, Gerald M., et al.. (1992). Adolescent health care in a large multispecialty prepaid group practice. Who provides it and how well are they doing?. PubMed. 156(6). 628–32. 8 indexed citations
16.
Borok, Gerald M.. (1987). Appropriate Utilization of Resources Program. PubMed. 2(2). 57–61. 1 indexed citations
17.
Charlton, R. W., et al.. (1963). The genetics of glucose-6-phosphate dehydrogenase deficiency.. PubMed. 37. 486–8. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nicola Motterlini Breakdown of academic impact, for papers by Amit D. Raval Breakdown of academic impact, for papers by John A. Merenich Breakdown of academic impact, for papers by Marietta Rottenkolber Breakdown of academic impact, for papers by E Bercoff Breakdown of academic impact, for papers by Magdalena Rosell Breakdown of academic impact, for papers by Luca Degli Esposti Breakdown of academic impact, for papers by Pietro Gallina Breakdown of academic impact, for papers by Edward F. Tierney Breakdown of academic impact, for papers by Ishak A. Mansi
Rankless by CCL
2026